Skip to main content

Advertisement

Table 7 Gene Sets enriched in lymph node positive patients

From: The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures

LN+ Gene Set Name Inferred Biological Activity Genes Represented ES
Long Term Remission SMID_BREAST_CANCER_NORMAL_LIKE_UP   420 0.65
WIELAND_UP_BY_HBV_INFECTION Immune 91 0.77
WALLACE_PROSTATE_CANCER_RACE_UP Increased Risk 259 0.66
MCLACHLAN_DENTAL_CARIES_UP Immune 225 0.59
KIM_LRRC3B_TARGETS Immune 28 0.85
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP Immune 78 0.67
VANTVEER_BREAST_CANCER_ESR1_DN ER down 197 0.59
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN   144 0.60
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP Immune 89 0.66
LEE_DIFFERENTIATING_T_LYMPHOCYTE Immune 138 0.61
Distant Metastasis NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON   86 −0.68
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON   83 −0.66
ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE EMT 60 −0.70
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP   28 −0.65
FARMER_BREAST_CANCER_CLUSTER_5   18 −0.74
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP   52 −0.55
MILI_PSEUDOPODIA_HAPTOTAXIS_UP Migration 348 −0.41
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER CNVs 81 −0.49
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP Differentiation 24 −0.64
HAMAI_APOPTOSIS_VIA_TRAIL_UP Apoptosis 463 −0.38